AndroFeme® is a testosterone therapy developed specifically for women and may be considered where clinically appropriate for symptoms associated with low testosterone levels, most commonly after menopause.
Testosterone plays a role in female physiology, and reduced levels may be associated with changes in wellbeing.
Following menopause, testosterone levels decline alongside oestrogen. In some women, this may be associated with:
Treatment may be considered as part of a broader clinical assessment.

Treatment is provided within a clinically supervised framework, including:
AndroFeme® is a prescription-only medicine. This product is not licensed in the UK and may be prescribed as an unlicensed medicine where clinically appropriate.